Wordt geladen...
Chronic Experimental Diabetes Accelerates Urinary Elimination of Deprenyl and its Metabolites
Many diabetic patients take several medications to treat diabetes-associated complications and other ailments. The mode of elimination of these drugs and their metabolites are poorly understood. The elimination of deprenyl, a MAO-B inhibitor, used for the treatment of the early stage of Parkinson’s...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bentham Science Publishers Ltd.
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2709476/ https://ncbi.nlm.nih.gov/pubmed/19662137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874104500802010001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|